Effect of Flos carthami on stress-activated protein kinase activity in the isolated reperfused rat heart

Molecular and Cellular Biochemistry

Volumn 207, Issue 1-2, 2000, Pages 41-47

  Siow, Yaw L ^a,c   Choy, Patrick C ^b   Leung, Winston M K ^a   Karmin, O ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF MANITOBA   (Canada)

^c UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Flos carthami; Heart; Ischemia; JNK; Reperfusion; SAP kinase

Indexed keywords

FLOS CARTHAMI EXTRACT; HERBACEOUS AGENT; STRESS ACTIVATED PROTEIN KINASE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL PROTECTION; CONTROLLED STUDY; DRUG EFFICACY; ENZYME ACTIVITY; HEART MUSCLE ISCHEMIA; HEART PROTECTION; ISOLATED HEART; MALE; NONHUMAN; RAT; REPERFUSION INJURY;

ANIMALIA; FLOS;

EID: 0034092331     PISSN: 03008177     EISSN: None     Source Type: Journal    
DOI: 10.1023/a:1017266628572     Document Type: Article

References (48)

1. Gottlieb RA, Burleson KO, Kloner RA, Babior BM, Engler RL: Reperfusion injury induces apoptosis in rabbit cardiomyocytes. J Clin Invest 94: 1621-1628, 1994.
2. Bromme HJ, Holtz J: Apoptosis in the heart: When and why? Mol Cell Biochem 163-164: 261-275, 1996
3. Fliss H, Gattinger D: Apoptosis in ischemic and reperfused rat myocardium. Circ Res 79: 949-956, 1996
4. Veinot JP, Gattinger DA, Fliss H: Early apoptosis in human myocardial infarcts. Hum Pathol 28: 485-492, 1997
5. Anversa P, Olivetti G, Leri A, Liu Y, Kajstura J: Myocyte cell death and ventricular remodeling (see comments). Curr Opin Nephrol Hypertens 6: 169-176, 1997
6. Levitzki A: Signal-transduction therapy. A novel approach to disease management. Eur J Biochem 226: 1-13, 1994
7. Levitzki A: Signal transduction interception as a novel approach to disease management. Ann N Y Acad Sci 766: 363-368, 1995
8. Levitzki A: Targeting signal transduction for disease therapy. Curr Opin Cell Biol 8: 239-244, 1996
9. Levitzki A: Targeting signal transduction for disease therapy. Med Oncol 14: 83-89, 1997
10. Powis G: Anticancer drugs acting against signaling pathways. Curr Opin Oncol 7: 554-559, 1995
11. Yu H, Xu LX: Separation and determination of flavonols in the flowers of Carthamus tinctorius by RP-HPLC. Yaoxue Xuebao 32: 120-122, 1997
12. Gong CF, Yu PL: Effects of Flos Carthami Co injection in the treatment of sclerema neonatorum. J Trad Chin Med 3: 141-143, 1983
13. Wang BZ, Yang MG, Pang L, Yu ZJ: [Effect of Hong-Hua (Flos Carthami) on the extent of myocardial ischemia in the different infarct zones following coronary occlusion in the dog (author's trans.)]. Yao Hsueh Hsueh Pao 14: 474-479, 1979.
14. Huang XL, Hattori M, Namba T: Effects of a Carthami Flos extract and its constituents on the beating amplitude of cultured myocardial cell sheets. Shoyakugaku Zasshi 46: 210-216, 1992
15. Man RY, Wong T, Choy PC: Effects of lysophosphoglycerides on cardiac arrhythmias. Life Sci 32: 1325-1330, 1983
16. Martorana PA, Linz W, Gobel H, Petry P, Scholkens BA: Effects of nicainoprol on reperfusion arrhythmia in the isolated working rat heart and on ischemia and reperfusion arrhythmia and myocardial infarct size in the anesthetized rat. Eur J Pharmacol 143: 391-401, 1987
17. Wright AR, Rees SA: Targeting ischaemia - cell swelling and drug efficacy. Trends Pharmacol Sci 18: 224-228, 1997
18. Maxwell SR, Lip GY: Reperfusion injury: A review of the pathophysiology, clinical manifestations and therapeutic options. Int J Cardiol 58: 95-117, 1997
19. Man RY, Choy PC: Lysophosphatidylcholine causes cardiac arrhythmia. J Mol Cell Cardiol 14: 173-175, 1982
20. Giffin M, Arthur G, Choy PC, Man RY: Lysophosphatidylcholine metabolism and cardiac arrhythmias. Can J Physiol Pharmacol 66: 185-189, 1988
21. Bogoyevitch MA, Ketterman AJ, Sugden PH: Cellular stresses differentially activate c-Jun N-terminal protein kinases and extracellular signal-regulated protein kinases in cultured ventricular myocytes. J Biol Chem 270: 29710-29717, 1995
22. Bogoyevitch MA, Gillespie Brown J, Ketterman AJ, Fuller SJ, Ben Levy R, Ashworth A, Marshall CJ, Sugden PH: Stimulation of the stress-activated mitogen-activated protein kinase subfamilies in perfused heart. p38/RK mitogen-activated protein kinases and c-Jun N-terminal kinases are activated by ischemia/reperfusion. Circ Res 79: 162-173, 1996
23. Laderoute KR, Webster KA: Hypoxia/reoxygenation stimulates Jun kinase activity through redox signaling in cardiac myocytes. Circ Res 80: 336-344, 1997
24. Tao J, Sanghera JS, Pelech SL, Wong G, Levy JG: Stimulation of stress-activated protein kinase and p38 HOG1 kinase in murine keratinocytes following photodynamic therapy with benzoporphyrin derivative. J Biol Chem 271: 27107-27115, 1996
25. Pombo CM, Kehrl JH, Sanchez I, Katz P, Avruch J, Zon LI, Woodgett JR, Force T, Kyriakis JM: Activation of the SAPK pathway by the human STE20 homologue germinal centre kinase. Nature 377: 750-754, 1995
26. Mizukami Y, Yoshioka K, Morimoto S, Yoshida K: A novel mechanism of JNK1 activation. Nuclear translocation and activation of JNK1 during ischemia and reperfusion. J Biol Chem 272: 16657-16662, 1997
27. Bradham CA, Stachlewitz RF, Gao W, Qian T, Jayadev S, Jenkins G, Hannun Y, Lemasters JJ, Thurman RG, Brenner DA: Reperfusion after liver transplantation in rats differentially activates the mitogen-activated protein kinases (see comments). Hepatology 25: 1128-1135, 1997
28. DiMari J, Megyesi J, Udvarhelyi N, Price P, Davis R, Safirstein R: N-acetyl cysteine ameliorates ischemic renal failure. Am J Physiol 272: F292-F298, 1997
29. Chen YR, Wang X, Templeton D, Davis RJ, Tan TH: The role of c-Jun N-terminal kinase (JNK) in apoptosis induced by ultraviolet C and gamma radiation. Duration of JNK activation may determine cell death and proliferation. J Biol Chem 271: 31929-31936, 1996
30. Chen YR, Meyer CF, Tan TH: Persistent activation of c-Jun N-terminal kinase 1 (JNK1) in gamma radiation-induced apoptosis. J Biol Chem 271: 631-634, 1996
31. Johnson NL, Gardner AM, Diener KM, Lange Carter CA, Gleavy J, Jarpe MB, Minden A, Karin M, Zon LI, Johnson GL: Signal transduction pathways regulated by mitogen-activated/extracellular response kinase kinase kinase induce cell death. J Biol Chem 271: 3229-3237, 1996
32. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME: Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331, 1995
33. Verheij M, Bose R, Lin XH, Yao B, Jarvis WD, Grant S, Birrer MJ, Szabo E, Zon LI, Kyriakis JM, Haimovitz Friedman A, Fuks Z, Kolesnick RN: Requirement for ceramide-initiated SAPK/JNK signalling in stress-induced apoptosis. Nature 380: 75-79, 1996
34. Zanke BW, Boudreau K, Rubie E, Winnett E, Tibbles LA, Zon L, Kyriakis J, Liu FF, Woodgett JR: The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr Biol 6: 606-613, 1996
35. Pena LA, Fuks Z, Kolesnick R: Stress-induced apoptosis and the sphingomyelin pathway. Biochem Pharmacol 53: 615-621, 1997
36. Force T, Pombo CM, Avruch JA, Bonventre JV, Kyriakis JM: Stress-activated protein kinases in cardiovascular disease. Circ Res 78: 947-953, 1996
37. Davis RJ: MAPKs: New JNK expands the group. Trends Biochem Sci 19: 470-473, 1994.
38. Cano E, Mahadevan LC: Parallel signal processing among mammalian MAPKs. Trends Biochem Sci 20: 117-122, 1995
39. Moriguchi T, Kawasaki H, Matsuda S, Gotoh Y, Nishida E: Evidence for multiple activators for stress-activated protein kinase/ c-Jun amino-terminal kinases. Existence of novel activators. J Biol Chem 270: 12969-12972, 1995
40. Davis RJ: Transcriptional regulation by MAP kinases. Mol Reprod Dev 42: 459-467, 1995
41. Zelinski TA, Savard JD, Man RY, Choy PC: Phosphatidylcholine biosynthesis in isolated hamster heart. J Biol Chem 255: 11423-11428, 1980
42. Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976
43. Clerk A, Fuller SJ, Michael A, Sugden PH: Stimulation of 'stress-regulated' mitogen-activated protein kinases (stress-activated protein kinases/c-Jun N-terminal kinases and p38-mitogen-activated protein kinases) in perfused rat hearts by oxidative and other stresses. J Biol Chem 273: 7228-7234, 1998
44. Ferrari R, Agnoletti L, Comini L, Gaia G, Bachetti T, Cargnoni A, Ceconi C, Curello S, Visioli O: Oxidative stress during myocardial ischaemia and heart failure. Eur Heart J 19(suppl B): B2-B11, 1998
45. Kallunki T, Su B, Tsigelny I, Sluss HK, Derijard B, Moore G, Davis R, Karin M: JNK2 contains a specificity-determining region responsible for efficient c-Jun binding and phosphorylation. Genes Dev 8: 2996-3007, 1994
46. Anversa P, Kajstura J, Olivetti G: Myocyte death in heart failure. Curr Opin Cardiol 11: 245-251, 1996
47. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, Reed JC, Anversa P: Apoptosis in the failing human heart. N Engl J Med 336: 1131-1141, 1997
48. Cosulich S, Clarke P: Apoptosis: Does stress kill? Curr Biol 6: 1586-1588, 1996